Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02538510What this trial is testingPembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryWho this might be right forHead and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more University of Washington 50
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT03274414What this trial is testingA Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal PassagesWho this might be right forParanasal Sinus CancerNasal Cavity TumorNasal Cavity Adenocarcinoma Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT03468218What this trial is testingPembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell CancerWho this might be right forMetastatic Head and Neck CarcinomaParanasal Sinus Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+21 more Emory University 36
Early research (Phase 1)Active Not RecruitingNCT04576091What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck CancerWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma+29 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00021047What this trial is testingEpirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorWho this might be right forEsophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT00081211What this trial is testingIntratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+19 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)WithdrawnNCT00041171What this trial is testingDocetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forAdult Solid TumorBreast CancerHead and Neck Cancer+3 more Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00004070What this trial is testingGene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 7
Testing effectiveness (Phase 2)UnknownNCT00003251What this trial is testingAmifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity University of Illinois at Chicago 46
Early research (Phase 1)Study completedNCT02158234What this trial is testingStereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckWho this might be right forSquamous Cell Carcinoma of the Head and Neck H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Looking for participantsNCT07156227What this trial is testingTesting the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell CarcinomaWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health